Skip to main content

Table 1 Demographics of the pediatric spine fusion population stratified by TXA Use

From: Evaluation of the safety of tranexamic acid use in pediatric patients undergoing spinal fusion surgery: a retrospective comparative cohort study

Characteristics

TXA (n = 402)

No TXA (n = 2,231)

All patients (n = 2,633)

p-value

Age (Average ± SD)

14.1 ± 3.11

14.1 ± 2.28

14.1 ± 2.99

0.87

Sex – Female, n (%)

271 (67.4)

1,426 (63.9)

1,697 (64.5)

0.18

Race – White, n (%)

1,449 (65.0)

282 (70.2)

1,731 (65.7)

0.20

Primary Fusion, n (%)

392 (97.5)

2,140 (95.9)

2,532 (96.2)

0.13

CCI (Average ± SD)

0.17 ± 0.38

0.17 ± 0.39

0.17 ± 0.39

0.99

  1. CCI Charlson comorbidity index is abbreviated